Harvett.Why would the MPS be trying to avoid our product anyway. I can't understand your argument. They obviously want our product or they wouldn't be trialing it.If we can't satisfy them no one else is currently going to. Fair enough by them to get us to tailor it to suit themselves because of the volume expected but if we get knocked back they're right back to square 1 and a long way from having anybody's product because the same process would have to be repeated all over again.Isn't it about curbing the drug problem which is why the time frame hasn't changed but the number used for trialing did.They need us as much as we need them. It might sound simplistic but it's the way i see it.
- Forums
- ASX - By Stock
- why now
Harvett.Why would the MPS be trying to avoid our product anyway....
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online